1
|
Salamzadeh J, Torabi Kachousangi S, Hamzelou S, Naderi S, Daneshvar E. Medication adherence and its possible associated factors in patients with acne vulgaris: A cross-sectional study of 200 patients in Iran. Dermatol Ther 2020; 33:e14408. [PMID: 33084227 DOI: 10.1111/dth.14408] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/18/2020] [Revised: 09/14/2020] [Accepted: 10/06/2020] [Indexed: 01/03/2023]
Abstract
There are several etiologic factors involved in the pathogenesis of acne vulgaris. Therefore, current treatment guidelines recommend applying different classes of medications for it. This makes medication adherence a challenging issue in acne patients. The current study was designed to assess medication adherence and its possible associated factors in patients with acne vulgaris. This study was performed on patients with acne vulgaris in two dermatology clinics of Imam Khomeini Hospital and Razi Hospital. A validated questionnaire (ECOB, Elaboration d'un outil d'evaluation de l'observance des traitements medicamenteux) was applied to evaluate adherence to topical and oral therapies. We assessed relationship between patients' medication adherence and their sociodemographic, medication, and medical histories. A total of 200 patients, 136 females (68%), and 64 males (32%), with a mean age of 22 years were entered into the study. Overall, only 30 out of 200 patients (15%) were adherent to their treatments. Based on the bivariate analyses, food exacerbations, and severity of the disease by the patient's opinion was significantly associated with overall medication adherence (P = .03). Moreover, patients who were more adherent to topical treatment were more adherent to systemic treatment, as well (P = .007). The current study showed that treatment adherence was very low among patients with acne vulgaris. It is recommended to educate patients on the proper use of anti-acne medications. Besides, it is highly recommended that physicians and pharmacists use ECOB questionnaire regularly to guide patients accurately with the use of their drug regimens.
Collapse
Affiliation(s)
- Jamshid Salamzadeh
- School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran
| | | | - Shahin Hamzelou
- Department of Dermatology, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran.,Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran
| | - Sina Naderi
- School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
| | - Elham Daneshvar
- Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran
| |
Collapse
|
2
|
Svendsen MT, Feldman SR, Tiedemann SN, Stochholm Sørensen AS, Rivas CMR, Andersen KE. Dermatology nurses view on factors related to Danish psoriasis patients' adherence to topical drugs: a focus group study. J DERMATOL TREAT 2019; 32:497-502. [PMID: 31664863 DOI: 10.1080/09546634.2019.1687817] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Abstract
BACKGROUND Topical medications are first-line treatment for mild-to-moderate psoriasis, but adherence is low, which negatively affects patients' outcomes and quality of life. Nurses can play a central role in patient care, particularly in improving adherence. OBJECTIVES To explore the experience of dermatology nurses with psoriasis patients' adherence to topical drugs. METHODS We conducted a semi-structured focus group study with 6 dermatology nurses and 2 dermatology nursing students. Participants were recruited from a dermatology hospital outpatient clinic. Data were analyzed by a systematic text condensation method with a phenomenological-hermeneutic approach. RESULTS Nurses experienced that factors such as social inequality, patient-centered nursing, and patients' quality of life can have an influence on adherence. CONCLUSION Optimal adherence to topical treatments is a complex exercise and is influenced by many different factors. Involving nurses when prescribing topical treatments may be beneficial since they are one of the most trustworthy professions and have a holistic view on psoriasis severity, patient preferences, health care resources available and socioeconomic factors.
Collapse
Affiliation(s)
- Mathias Tiedemann Svendsen
- Research Unit of the Dermato-Venerology and Allergy Center, University of Southern Denmark, Odense, Denmark
| | - Steven R Feldman
- Research Unit of the Dermato-Venerology and Allergy Center, University of Southern Denmark, Odense, Denmark.,Department of Dermatology (Center for Dermatology Research), Wake Forest School of Medicine, Winston-Salem, NC, USA
| | | | | | | | - Klaus Ejner Andersen
- Research Unit of the Dermato-Venerology and Allergy Center, University of Southern Denmark, Odense, Denmark
| |
Collapse
|
3
|
Sevimli Dikicier B. Topical treatment of acne vulgaris: efficiency, side effects, and adherence rate. J Int Med Res 2019; 47:2987-2992. [PMID: 31122106 PMCID: PMC6683887 DOI: 10.1177/0300060519847367] [Citation(s) in RCA: 54] [Impact Index Per Article: 10.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2018] [Accepted: 04/05/2019] [Indexed: 11/15/2022] Open
Abstract
Objective Adherence is a problem in the topical treatment of acne. This study was designed to evaluate the efficiency of current topical treatment and adherence in patients. Methods Patients with acne vulgaris who had recently been prescribed a topical therapy were selected. A dermatologist-directed questionnaire was completed. Demographic data, acne severity, treatment and the manner of use, side effects, and reason for discontinuation were recorded. Results A total 250 patients were included, 178 female (71.2%) and 72 male (28.8%) participants, mean age was 18.6 ± 2.8 years. Of 250 patients, 114 (45.6%) had given up therapy for two reasons: unresponsiveness in 71 (62.3%) and side effects in 43 (37.7%) patients. For antibacterial treatments, the rate of unresponsiveness was higher but the rate of side effects was lower. Discontinuation owing to unresponsiveness was higher in patients with severe acne. Side effects were higher in patients with comedonal-type acne. The lowest rates of side effects and discontinuation were among every-other-night users. Conclusion In this study, patients with acne gave up treatment owing to side effects and unresponsiveness, which reduced the treatment efficiency.
Collapse
Affiliation(s)
- B Sevimli Dikicier
- Sakarya University Faculty of Medicine, Training and Research Hospital, Department of Dermatology, Sakarya 54100, Turkey
| |
Collapse
|
4
|
Hayran Y, İncel Uysal P, Öktem A, Aksoy GG, Akdoğan N, Yalçın B. Factors affecting adherence and patient satisfaction with treatment: a cross-sectional study of 500 patients with acne vulgaris. J DERMATOL TREAT 2019; 32:64-69. [PMID: 31076012 DOI: 10.1080/09546634.2019.1618434] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Abstract
Background: Acne Vulgaris is a chronic inflammatory disease that requires long-term treatment. Adherence to treatment is a problem in chronic diseases and may affect treatment outcomes.Objective: We aim to investigate treatment adherence and satisfaction of patients with acne and identify independent factors that affect them.Methods: Five hundred patients with acne were included in this cross-sectional study. Demographic and clinical characteristics of the patients were recorded. Severity of acne was assessed using the Investigator Global Assessment (IGA) scale, and a five-point Likert scale was used to assess patients' satisfaction and adherence.Results: Adherence to treatment was poor in 64.4% of the patients. Multivariate logistic regression analysis showed that using oral isotretinoin (OR: 4.1, 95% CI 2.44-6.92, p < .001) and satisfaction with treatment (OR: 2.1, 95% CI 1.31-3.43, p = .002) were independent factors that affect adherence in patients. 51.8% of the patients were satisfied with their treatments and treatment satisfaction was higher in females (OR: 2.2, 95% CI 1.3-3.8, p = .004) and patients using oral isotretinoin (OR: 14.8, 95% CI 9.4-23.2, p < .001).Conclusions: Treatment adherence is poor among patients with acne. Identifying the factor that affects adherence may help the dermatologist recognize non-adherent patients and develop strategies to improve adherence.
Collapse
Affiliation(s)
- Yıldız Hayran
- Department of Dermatology, Numune Training and Research Hospital, Ankara, Turkey
| | - Pınar İncel Uysal
- Department of Dermatology, Numune Training and Research Hospital, Ankara, Turkey
| | - Ayşe Öktem
- Department of Dermatology, Numune Training and Research Hospital, Ankara, Turkey
| | - Güneş Gür Aksoy
- Department of Dermatology, Numune Training and Research Hospital, Ankara, Turkey
| | - Neslihan Akdoğan
- Department of Dermatology, Numune Training and Research Hospital, Ankara, Turkey
| | - Başak Yalçın
- Department of Dermatology, Numune Training and Research Hospital, Ankara, Turkey
| |
Collapse
|
5
|
Myhill T, Coulson W, Nixon P, Royal S, McCormack T, Kerrouche N. Use of Supplementary Patient Education Material Increases Treatment Adherence and Satisfaction Among Acne Patients Receiving Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel in Primary Care Clinics: A Multicenter, Randomized, Controlled Clinical Study. Dermatol Ther (Heidelb) 2017; 7:515-524. [PMID: 29027127 PMCID: PMC5698202 DOI: 10.1007/s13555-017-0203-4] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/25/2017] [Indexed: 11/03/2022] Open
Abstract
INTRODUCTION Poor adherence to acne treatment may lead to unnecessary treatments, increased healthcare costs, and reduced quality of life (QoL). This multicenter study evaluated the effect of supplementary patient education material (SEM) (a short video, information card, and additional information available online) on treatment adherence and satisfaction among acne patients treated with the fixed-dose combination adapalene 0.1%/benzoyl peroxide 2.5% gel (A/BPO) in primary care clinics versus (1) standard-of-care patient education (SOCPE) (package insert and oral instruction) and (2) SOCPE plus more frequent clinic visits. METHODS Subjects with acne were randomized to receive once-daily A/BPO for 12 weeks plus (1) SEM in addition to SOCPE; (2) SOCPE only with two additional visits; or (3) SOCPE only. Other assessments included a subject appreciation questionnaire, a physician questionnaire, and safety. RESULTS Ninety-seven subjects were enrolled. At baseline, most (87.6%) had mild to moderate acne. Better adherence was observed in the A/BPO + SEM group compared with A/BPO + more visits or A/BPO alone [mean 63.1%, 48.2% (p = 0.0206), and 56.5%, respectively]. The A/BPO + SEM group had more subjects with greater than 75% adherence (45%, 30.4%, and 25%, respectively). According to the subject appreciation questionnaire, the SEM was more helpful to adhere to treatment (56.7%) versus more visits (32.3%) and A/BPO alone (15.2%), better use the product (70%, 61.3%, and 54.5%, respectively), and better manage skin irritation (53.3%, 48.4%, and 36.4%, respectively). All physicians were satisfied with the SEM and 90% would consider using it in their practice. Safety assessment showed fewer treatment-related adverse events in the A/BPO + SEM group. CONCLUSION Use of the SEM may increase adherence of acne patients treated with once-daily A/BPO gel in primary care, consequently improving treatment and QoL in the long term. FUNDING Nestle Skin Health-Galderma R&D. TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT02307266.
Collapse
Affiliation(s)
| | | | | | - Simon Royal
- University of Nottingham Health Service Cripps Health Centre, Nottingham, UK
| | - Terry McCormack
- Hull York Medical School, Spring Vale Medical Centre, Whitby, UK
| | | |
Collapse
|
6
|
Chernyshov PV, Zouboulis CC, Tomas-Aragones L, Jemec GB, Manolache L, Tzellos T, Sampogna F, Evers AWM, Dessinioti C, Marron SE, Bettoli V, van Cranenburgh OD, Svensson A, Liakou AI, Poot F, Szepietowski JC, Salek MS, Finlay AY. Quality of life measurement in acne. Position Paper of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes and Acne, Rosacea and Hidradenitis Suppurativa. J Eur Acad Dermatol Venereol 2017; 32:194-208. [PMID: 28898474 DOI: 10.1111/jdv.14585] [Citation(s) in RCA: 41] [Impact Index Per Article: 5.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2017] [Accepted: 09/05/2017] [Indexed: 12/13/2022]
Abstract
Acne causes profound negative psychological and social effects on the quality of life (QoL) of patients. The European Dermatology Forum S3-Guideline for the Treatment of Acne recommended adopting a QoL measure as an integral part of acne management. Because of constantly growing interest in health-related QoL assessment in acne and because of the high impact of acne on patients' lives, the European Academy of Dermatology and Venereology Task Force on QoL and Patient Oriented Outcomes and the Task Force on Acne, Rosacea and Hidradenitis Suppurativa have documented the QoL instruments that have been used in acne patients, with information on validation, purposes of their usage, description of common limitations and mistakes in their usage and overall recommendations.
Collapse
Affiliation(s)
- P V Chernyshov
- Department of Dermatology and Venereology, National Medical University, Kiev, Ukraine
| | - C C Zouboulis
- Departments of Dermatology, Venereology, Allergology and Immunology, Dessau Medical Center, Brandenburg Medical School Theodore Fontane, Dessau, Germany
| | - L Tomas-Aragones
- Department of Psychology, University of Zaragoza, Aragon Health Sciences Institute (IACS), Zaragoza, Spain
| | - G B Jemec
- Department of Dermatology, Zealand University Hospital, Roskilde, Denmark
| | - L Manolache
- Dermatology, Dali Medical, Bucharest, Romania
| | - T Tzellos
- Department of Dermatology, Faculty of Health Sciences, University Hospital of North Norway, Troms, Norway
| | - F Sampogna
- Clinical Epidemiology Unit, Istituto Dermopatico dell'Immacolata (IDI)-IRCCS FLMM, Rome, Italy
| | - A W M Evers
- Health, Medical, and Neuropsychology Unit, Leiden University, Leiden, The Netherlands
| | - C Dessinioti
- Department of Dermatology, Andreas Syggros Hospital, Athens, Greece
| | - S E Marron
- Department of Dermatology, Royo Villanova Hospital, Aragon Health Sciences Institute (IACS), Zaragoza, Spain
| | - V Bettoli
- Department of Medical Sciences, Section of Dermatology, University of Ferrara, Ferrara, Italy
| | - O D van Cranenburgh
- Department of Medical Psychology, Academic Medical Center, Amsterdam, The Netherlands.,Dutch Skin Foundation, Nieuwegein, The Netherlands
| | - A Svensson
- Department of Dermatology and Venereology, Skane University Hospital, Malmö, Sweden
| | - A I Liakou
- 2nd Department of Dermatology and Venereology, National and Kapodistrian University of Athens Medical School, "Attikon" General University Hospital, Athens, Greece
| | - F Poot
- Department of Dermatology, ULB-Erasme Hospital, Brussels, Belgium
| | - J C Szepietowski
- Department of Dermatology, Wroclaw Medical University, Wroclaw, Poland
| | - M S Salek
- Department of Pharmacy, Pharmacology and Postgraduate Medicine, School of Life & Medical Sciences, University of Hertfordshire, Hatfield, UK
| | - A Y Finlay
- Department of Dermatology and Wound Healing, Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK
| |
Collapse
|
7
|
Gieler U, Gieler T, Kupfer JP. Acne and quality of life - impact and management. J Eur Acad Dermatol Venereol 2016; 29 Suppl 4:12-4. [PMID: 26059729 DOI: 10.1111/jdv.13191] [Citation(s) in RCA: 81] [Impact Index Per Article: 10.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/16/2015] [Accepted: 04/16/2015] [Indexed: 11/27/2022]
Abstract
Acne is a common skin disease with a high prevalence in adolescents and young adults. In addition to physical effects such as permanent scarring and disfigurement, acne has long-lasting psychosocial effects that affect the patient's quality of life. Depression, social isolation and suicidal ideation are frequent comorbidities of acne that should not be neglected in the therapy of acne patients. Research evidence suggests that the impairment of quality of life can be alleviated by appropriate topical acne treatment.
Collapse
Affiliation(s)
- U Gieler
- Department of Dermatology and Allergology, University Clinic Giessen (UGKM), Giessen, Germany
| | - T Gieler
- Vitos Clinics for Psychiatry, Psychosomatic Medicine, and Psychotherapy Giessen, Giessen, Germany
| | - J P Kupfer
- Institute of Medical Psychology, University of Giessen, Giessen, Germany
| |
Collapse
|
8
|
Asai Y, Baibergenova A, Dutil M, Humphrey S, Hull P, Lynde C, Poulin Y, Shear NH, Tan J, Toole J, Zip C. Management of acne: Canadian clinical practice guideline. CMAJ 2015; 188:118-126. [PMID: 26573753 DOI: 10.1503/cmaj.140665] [Citation(s) in RCA: 58] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
Affiliation(s)
- Yuka Asai
- Department of Medicine (Asai), Queen's University, Kingston, Ont.; private practice (Baibergenova), Markham, Ont.; Dermatology (Dutil), Women's College Hospital, University of Toronto, Toronto, Ont.; Department of Dermatology and Skin Science (Humphrey), University of British Columbia, Vancouver, BC; Dermatology (Hull), University of Saskatchewan, Saskatoon, Sask.; Department of Medicine (Lynde), University of Toronto, Toronto, Ont.; Centre dermatologique du Québec (Poulin), Laval University, Laval, Que.; Dermatology and Clinical Pharmacology (Shear), Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ont.; Department of Medicine (Tan), University of Western Ontario, Windsor, Ont.; Section of Dermatology (Toole), Department of Medicine, University of Manitoba, Winnipeg, Man.; Division of Dermatology (Zip), Department of Medicine, University of Calgary, Calgary, Alta
| | - Akerke Baibergenova
- Department of Medicine (Asai), Queen's University, Kingston, Ont.; private practice (Baibergenova), Markham, Ont.; Dermatology (Dutil), Women's College Hospital, University of Toronto, Toronto, Ont.; Department of Dermatology and Skin Science (Humphrey), University of British Columbia, Vancouver, BC; Dermatology (Hull), University of Saskatchewan, Saskatoon, Sask.; Department of Medicine (Lynde), University of Toronto, Toronto, Ont.; Centre dermatologique du Québec (Poulin), Laval University, Laval, Que.; Dermatology and Clinical Pharmacology (Shear), Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ont.; Department of Medicine (Tan), University of Western Ontario, Windsor, Ont.; Section of Dermatology (Toole), Department of Medicine, University of Manitoba, Winnipeg, Man.; Division of Dermatology (Zip), Department of Medicine, University of Calgary, Calgary, Alta
| | - Maha Dutil
- Department of Medicine (Asai), Queen's University, Kingston, Ont.; private practice (Baibergenova), Markham, Ont.; Dermatology (Dutil), Women's College Hospital, University of Toronto, Toronto, Ont.; Department of Dermatology and Skin Science (Humphrey), University of British Columbia, Vancouver, BC; Dermatology (Hull), University of Saskatchewan, Saskatoon, Sask.; Department of Medicine (Lynde), University of Toronto, Toronto, Ont.; Centre dermatologique du Québec (Poulin), Laval University, Laval, Que.; Dermatology and Clinical Pharmacology (Shear), Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ont.; Department of Medicine (Tan), University of Western Ontario, Windsor, Ont.; Section of Dermatology (Toole), Department of Medicine, University of Manitoba, Winnipeg, Man.; Division of Dermatology (Zip), Department of Medicine, University of Calgary, Calgary, Alta
| | - Shannon Humphrey
- Department of Medicine (Asai), Queen's University, Kingston, Ont.; private practice (Baibergenova), Markham, Ont.; Dermatology (Dutil), Women's College Hospital, University of Toronto, Toronto, Ont.; Department of Dermatology and Skin Science (Humphrey), University of British Columbia, Vancouver, BC; Dermatology (Hull), University of Saskatchewan, Saskatoon, Sask.; Department of Medicine (Lynde), University of Toronto, Toronto, Ont.; Centre dermatologique du Québec (Poulin), Laval University, Laval, Que.; Dermatology and Clinical Pharmacology (Shear), Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ont.; Department of Medicine (Tan), University of Western Ontario, Windsor, Ont.; Section of Dermatology (Toole), Department of Medicine, University of Manitoba, Winnipeg, Man.; Division of Dermatology (Zip), Department of Medicine, University of Calgary, Calgary, Alta
| | - Peter Hull
- Department of Medicine (Asai), Queen's University, Kingston, Ont.; private practice (Baibergenova), Markham, Ont.; Dermatology (Dutil), Women's College Hospital, University of Toronto, Toronto, Ont.; Department of Dermatology and Skin Science (Humphrey), University of British Columbia, Vancouver, BC; Dermatology (Hull), University of Saskatchewan, Saskatoon, Sask.; Department of Medicine (Lynde), University of Toronto, Toronto, Ont.; Centre dermatologique du Québec (Poulin), Laval University, Laval, Que.; Dermatology and Clinical Pharmacology (Shear), Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ont.; Department of Medicine (Tan), University of Western Ontario, Windsor, Ont.; Section of Dermatology (Toole), Department of Medicine, University of Manitoba, Winnipeg, Man.; Division of Dermatology (Zip), Department of Medicine, University of Calgary, Calgary, Alta
| | - Charles Lynde
- Department of Medicine (Asai), Queen's University, Kingston, Ont.; private practice (Baibergenova), Markham, Ont.; Dermatology (Dutil), Women's College Hospital, University of Toronto, Toronto, Ont.; Department of Dermatology and Skin Science (Humphrey), University of British Columbia, Vancouver, BC; Dermatology (Hull), University of Saskatchewan, Saskatoon, Sask.; Department of Medicine (Lynde), University of Toronto, Toronto, Ont.; Centre dermatologique du Québec (Poulin), Laval University, Laval, Que.; Dermatology and Clinical Pharmacology (Shear), Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ont.; Department of Medicine (Tan), University of Western Ontario, Windsor, Ont.; Section of Dermatology (Toole), Department of Medicine, University of Manitoba, Winnipeg, Man.; Division of Dermatology (Zip), Department of Medicine, University of Calgary, Calgary, Alta
| | - Yves Poulin
- Department of Medicine (Asai), Queen's University, Kingston, Ont.; private practice (Baibergenova), Markham, Ont.; Dermatology (Dutil), Women's College Hospital, University of Toronto, Toronto, Ont.; Department of Dermatology and Skin Science (Humphrey), University of British Columbia, Vancouver, BC; Dermatology (Hull), University of Saskatchewan, Saskatoon, Sask.; Department of Medicine (Lynde), University of Toronto, Toronto, Ont.; Centre dermatologique du Québec (Poulin), Laval University, Laval, Que.; Dermatology and Clinical Pharmacology (Shear), Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ont.; Department of Medicine (Tan), University of Western Ontario, Windsor, Ont.; Section of Dermatology (Toole), Department of Medicine, University of Manitoba, Winnipeg, Man.; Division of Dermatology (Zip), Department of Medicine, University of Calgary, Calgary, Alta
| | - Neil H Shear
- Department of Medicine (Asai), Queen's University, Kingston, Ont.; private practice (Baibergenova), Markham, Ont.; Dermatology (Dutil), Women's College Hospital, University of Toronto, Toronto, Ont.; Department of Dermatology and Skin Science (Humphrey), University of British Columbia, Vancouver, BC; Dermatology (Hull), University of Saskatchewan, Saskatoon, Sask.; Department of Medicine (Lynde), University of Toronto, Toronto, Ont.; Centre dermatologique du Québec (Poulin), Laval University, Laval, Que.; Dermatology and Clinical Pharmacology (Shear), Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ont.; Department of Medicine (Tan), University of Western Ontario, Windsor, Ont.; Section of Dermatology (Toole), Department of Medicine, University of Manitoba, Winnipeg, Man.; Division of Dermatology (Zip), Department of Medicine, University of Calgary, Calgary, Alta
| | - Jerry Tan
- Department of Medicine (Asai), Queen's University, Kingston, Ont.; private practice (Baibergenova), Markham, Ont.; Dermatology (Dutil), Women's College Hospital, University of Toronto, Toronto, Ont.; Department of Dermatology and Skin Science (Humphrey), University of British Columbia, Vancouver, BC; Dermatology (Hull), University of Saskatchewan, Saskatoon, Sask.; Department of Medicine (Lynde), University of Toronto, Toronto, Ont.; Centre dermatologique du Québec (Poulin), Laval University, Laval, Que.; Dermatology and Clinical Pharmacology (Shear), Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ont.; Department of Medicine (Tan), University of Western Ontario, Windsor, Ont.; Section of Dermatology (Toole), Department of Medicine, University of Manitoba, Winnipeg, Man.; Division of Dermatology (Zip), Department of Medicine, University of Calgary, Calgary, Alta.
| | - John Toole
- Department of Medicine (Asai), Queen's University, Kingston, Ont.; private practice (Baibergenova), Markham, Ont.; Dermatology (Dutil), Women's College Hospital, University of Toronto, Toronto, Ont.; Department of Dermatology and Skin Science (Humphrey), University of British Columbia, Vancouver, BC; Dermatology (Hull), University of Saskatchewan, Saskatoon, Sask.; Department of Medicine (Lynde), University of Toronto, Toronto, Ont.; Centre dermatologique du Québec (Poulin), Laval University, Laval, Que.; Dermatology and Clinical Pharmacology (Shear), Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ont.; Department of Medicine (Tan), University of Western Ontario, Windsor, Ont.; Section of Dermatology (Toole), Department of Medicine, University of Manitoba, Winnipeg, Man.; Division of Dermatology (Zip), Department of Medicine, University of Calgary, Calgary, Alta
| | - Catherine Zip
- Department of Medicine (Asai), Queen's University, Kingston, Ont.; private practice (Baibergenova), Markham, Ont.; Dermatology (Dutil), Women's College Hospital, University of Toronto, Toronto, Ont.; Department of Dermatology and Skin Science (Humphrey), University of British Columbia, Vancouver, BC; Dermatology (Hull), University of Saskatchewan, Saskatoon, Sask.; Department of Medicine (Lynde), University of Toronto, Toronto, Ont.; Centre dermatologique du Québec (Poulin), Laval University, Laval, Que.; Dermatology and Clinical Pharmacology (Shear), Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ont.; Department of Medicine (Tan), University of Western Ontario, Windsor, Ont.; Section of Dermatology (Toole), Department of Medicine, University of Manitoba, Winnipeg, Man.; Division of Dermatology (Zip), Department of Medicine, University of Calgary, Calgary, Alta
| |
Collapse
|
9
|
Ramien ML, Ondrejchak S, Gendron R, Hatami A, McCuaig CC, Powell J, Marcoux D. Quality of life in pediatric patients before and after cosmetic camouflage of visible skin conditions. J Am Acad Dermatol 2014; 71:935-40. [DOI: 10.1016/j.jaad.2014.07.029] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/20/2014] [Revised: 07/11/2014] [Accepted: 07/20/2014] [Indexed: 10/24/2022]
|
10
|
Lynde C, Tan J, Andriessen A, Barankin B, Dutil M, Gilbert M, Hong CH, Humphrey S, Rochette L, Toole J, Thomas R, Vender R, Wiseman M, Zip C. A Consensus on Acne Management Focused on Specific Patient Features. J Cutan Med Surg 2014; 18:243-55. [DOI: 10.2310/7750.2013.13154] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
Background: Most treatment guidelines for acne are based on clinical severity. Our objective was to expand that approach to one that also comprised individualized patient features: a case-based approach. Methods: An expert panel of Canadian dermatologists was established to develop demographic and clinical features considered to be particularly important in acne treatment selection. A nominal group consensus process was used for inclusion of features and corresponding appropriate treatments. Results: Consensus was achieved on the following statements: follicular epithelial dysfunction contributes to acne pathogenesis; inflammation from underlying disease(s) or prior treatment may impact further patient management; management focusing on specific patient features and on addressing psychosocial factors, including impact on quality of life, may improve treatment adherence and outcomes; and case-based scenarios are a practical approach to illustrate the effect of these factors. To address the latter, eight case profiles were developed. Conclusions: Management of acne should be based on multifactorial considerations beyond clinically determined acne severity and should include patient-reported impact, gender, skin sensitivity (including preexisting dermatoses), and phototype.
Collapse
Affiliation(s)
- Charles Lynde
- From University of Toronto, Toronto, ON; University of Western Ontario, Windsor, ON; Andriessen Consultants Malden and UMC St Radboud Nijmegen, The Netherlands; Toronto Dermatology Center, Toronto, ON; University of British Columbia, Vancouver, BC; Centre Dermatologique du Québec, QC; University of Manitoba, Winnipeg, MB; Department of Medicine, McMaster University, Hamilton, ON; University of Calgary Calgary, AB
| | - Jerry Tan
- From University of Toronto, Toronto, ON; University of Western Ontario, Windsor, ON; Andriessen Consultants Malden and UMC St Radboud Nijmegen, The Netherlands; Toronto Dermatology Center, Toronto, ON; University of British Columbia, Vancouver, BC; Centre Dermatologique du Québec, QC; University of Manitoba, Winnipeg, MB; Department of Medicine, McMaster University, Hamilton, ON; University of Calgary Calgary, AB
| | - Anneke Andriessen
- From University of Toronto, Toronto, ON; University of Western Ontario, Windsor, ON; Andriessen Consultants Malden and UMC St Radboud Nijmegen, The Netherlands; Toronto Dermatology Center, Toronto, ON; University of British Columbia, Vancouver, BC; Centre Dermatologique du Québec, QC; University of Manitoba, Winnipeg, MB; Department of Medicine, McMaster University, Hamilton, ON; University of Calgary Calgary, AB
| | - Benjamin Barankin
- From University of Toronto, Toronto, ON; University of Western Ontario, Windsor, ON; Andriessen Consultants Malden and UMC St Radboud Nijmegen, The Netherlands; Toronto Dermatology Center, Toronto, ON; University of British Columbia, Vancouver, BC; Centre Dermatologique du Québec, QC; University of Manitoba, Winnipeg, MB; Department of Medicine, McMaster University, Hamilton, ON; University of Calgary Calgary, AB
| | - Maha Dutil
- From University of Toronto, Toronto, ON; University of Western Ontario, Windsor, ON; Andriessen Consultants Malden and UMC St Radboud Nijmegen, The Netherlands; Toronto Dermatology Center, Toronto, ON; University of British Columbia, Vancouver, BC; Centre Dermatologique du Québec, QC; University of Manitoba, Winnipeg, MB; Department of Medicine, McMaster University, Hamilton, ON; University of Calgary Calgary, AB
| | - Martin Gilbert
- From University of Toronto, Toronto, ON; University of Western Ontario, Windsor, ON; Andriessen Consultants Malden and UMC St Radboud Nijmegen, The Netherlands; Toronto Dermatology Center, Toronto, ON; University of British Columbia, Vancouver, BC; Centre Dermatologique du Québec, QC; University of Manitoba, Winnipeg, MB; Department of Medicine, McMaster University, Hamilton, ON; University of Calgary Calgary, AB
| | - Chih-ho Hong
- From University of Toronto, Toronto, ON; University of Western Ontario, Windsor, ON; Andriessen Consultants Malden and UMC St Radboud Nijmegen, The Netherlands; Toronto Dermatology Center, Toronto, ON; University of British Columbia, Vancouver, BC; Centre Dermatologique du Québec, QC; University of Manitoba, Winnipeg, MB; Department of Medicine, McMaster University, Hamilton, ON; University of Calgary Calgary, AB
| | - Shannon Humphrey
- From University of Toronto, Toronto, ON; University of Western Ontario, Windsor, ON; Andriessen Consultants Malden and UMC St Radboud Nijmegen, The Netherlands; Toronto Dermatology Center, Toronto, ON; University of British Columbia, Vancouver, BC; Centre Dermatologique du Québec, QC; University of Manitoba, Winnipeg, MB; Department of Medicine, McMaster University, Hamilton, ON; University of Calgary Calgary, AB
| | - Linda Rochette
- From University of Toronto, Toronto, ON; University of Western Ontario, Windsor, ON; Andriessen Consultants Malden and UMC St Radboud Nijmegen, The Netherlands; Toronto Dermatology Center, Toronto, ON; University of British Columbia, Vancouver, BC; Centre Dermatologique du Québec, QC; University of Manitoba, Winnipeg, MB; Department of Medicine, McMaster University, Hamilton, ON; University of Calgary Calgary, AB
| | - Jack Toole
- From University of Toronto, Toronto, ON; University of Western Ontario, Windsor, ON; Andriessen Consultants Malden and UMC St Radboud Nijmegen, The Netherlands; Toronto Dermatology Center, Toronto, ON; University of British Columbia, Vancouver, BC; Centre Dermatologique du Québec, QC; University of Manitoba, Winnipeg, MB; Department of Medicine, McMaster University, Hamilton, ON; University of Calgary Calgary, AB
| | - Richard Thomas
- From University of Toronto, Toronto, ON; University of Western Ontario, Windsor, ON; Andriessen Consultants Malden and UMC St Radboud Nijmegen, The Netherlands; Toronto Dermatology Center, Toronto, ON; University of British Columbia, Vancouver, BC; Centre Dermatologique du Québec, QC; University of Manitoba, Winnipeg, MB; Department of Medicine, McMaster University, Hamilton, ON; University of Calgary Calgary, AB
| | - Ronald Vender
- From University of Toronto, Toronto, ON; University of Western Ontario, Windsor, ON; Andriessen Consultants Malden and UMC St Radboud Nijmegen, The Netherlands; Toronto Dermatology Center, Toronto, ON; University of British Columbia, Vancouver, BC; Centre Dermatologique du Québec, QC; University of Manitoba, Winnipeg, MB; Department of Medicine, McMaster University, Hamilton, ON; University of Calgary Calgary, AB
| | - Marni Wiseman
- From University of Toronto, Toronto, ON; University of Western Ontario, Windsor, ON; Andriessen Consultants Malden and UMC St Radboud Nijmegen, The Netherlands; Toronto Dermatology Center, Toronto, ON; University of British Columbia, Vancouver, BC; Centre Dermatologique du Québec, QC; University of Manitoba, Winnipeg, MB; Department of Medicine, McMaster University, Hamilton, ON; University of Calgary Calgary, AB
| | - Catherine Zip
- From University of Toronto, Toronto, ON; University of Western Ontario, Windsor, ON; Andriessen Consultants Malden and UMC St Radboud Nijmegen, The Netherlands; Toronto Dermatology Center, Toronto, ON; University of British Columbia, Vancouver, BC; Centre Dermatologique du Québec, QC; University of Manitoba, Winnipeg, MB; Department of Medicine, McMaster University, Hamilton, ON; University of Calgary Calgary, AB
| |
Collapse
|
11
|
Acne subject preference for pump over tube for dispensing fixed-dose combination adapalene 0.1%-benzoyl peroxide 2.5% gel. Dermatol Ther (Heidelb) 2014; 4:61-70. [PMID: 24919432 PMCID: PMC4065281 DOI: 10.1007/s13555-014-0054-1] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2014] [Indexed: 11/25/2022] Open
Abstract
Introduction Acne is a chronic inflammatory disease. Key to a patient’s success on fixed-dose adapalene–benzoyl peroxide (BPO) gel is ensuring adherence. Use of a pump system to deliver a pre-measured amount of gel with each pressure enables application of a more consistent dose vs. the tube, which should improve adherence. In the present study, we evaluate patient preference for two different containers for dispensing adapalene–BPO gel. Methods In this 15-day, open-label study, 300 subjects were asked to treat their acne using fixed-dose adapalene 0.1%–BPO 2.5% gel dispensed in either a tube or a pump once-daily for up to 7 days. At week 1, subjects switched to the alternative packaging design for the same timeframe. At the end of the treatment period, subjects were asked to complete a subject preference survey. Results Among subjects completing the survey (n = 291), 79.0% (n = 230) preferred the pump for dispensing adapalene–BPO gel and 21.0% (n = 61) preferred the tube (p < 0.001). The top three characteristics of the pump were that it was easy to use (89.0%; n = 259/291), clean (73.2%; n = 213/291) and convenient (69.4%; n = 202/291). When asked to rate their experience with using the pump, 91.8% (n = 267/291; p < 0.001) of subjects reported being satisfied on a self-assessment scale. The majority of subjects stated they would tell their doctor about their preference for the pump next time adapalene–BPO gel was prescribed (76.6%; n = 223/291; p < 0.001) and would prefer the pump if both containers cost the same amount (80.1%; n = 233/291; p < 0.001). Conclusion Patients prefer using a pump instead of a tube to dispense adapalene–BPO gel. This delivery mechanism helps to ensure consistent application and thus may improve patient adherence to the prescribed acne treatment regimen. Electronic supplementary material The online version of this article (doi:10.1007/s13555-014-0054-1) contains supplementary material, which is available to authorized users.
Collapse
|
12
|
Snyder S, Crandell I, Davis SA, Feldman SR. Medical adherence to acne therapy: a systematic review. Am J Clin Dermatol 2014; 15:87-94. [PMID: 24481999 DOI: 10.1007/s40257-014-0063-y] [Citation(s) in RCA: 34] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Abstract
BACKGROUND Poor adherence of acne patients to treatment may equate to poor clinical efficacy, increased healthcare costs, and unnecessary treatments. Authors have investigated risk factors for poor medical adherence and how to improve this difficult problem in the context of acne. OBJECTIVE This systematic review aims to describe what methods have been used to measure adherence, what is known about acne patients' adherence to treatment, and the factors affecting adherence. METHODS A MEDLINE search was performed for randomized controlled trials published between 1978 and June 2013, focusing on patient adherence to prescribed acne medications. A test for equality of proportions was performed on studies of similar design to collectively analyze adherence to oral versus topical medication. The self-reported adherence data collected from these clinical trials were then compared with adherence data from a pharmacy database study. RESULTS Studies varied in modalities of data collection, but the majority utilized subjective methods. Topical therapies were more often studied than oral. The overall oral adherence rate, as calculated by a test of equality of proportions, was 76.3%, while the overall topical adherence rate was 75.8% (p=0.927). The occurrence of side effects and young age were cited as the top reasons for poor adherence, followed by forgetfulness. LIMITATIONS The MEDLINE search resulted in a limited sample of adherence studies. In addition, there is currently no standardized or fully validated method of measurement, allowing for variability in what was considered 'adherent'. Lastly, data collected via subjective methods cannot guarantee reliable results. CONCLUSIONS Overall, the values reflected a population adherent to both topical and oral medications, with no significant difference in adherence between the two. However, the methodologies used by many of the studies were weak, and the findings are not consistent with results of more objective measures of adherence. The leading factors that contribute to poor adherence may be reduced with enhanced patient consultation, reminder systems, and education.
Collapse
|
13
|
Thiboutot D, Gollnick H, Bettoli V, Dréno B, Kang S, Leyden JJ, Shalita A, Torres V. Oral isotretinoin and pregnancy prevention programmes. Br J Dermatol 2012; 166:466-7; author reply 467-8. [PMID: 21985025 DOI: 10.1111/j.1365-2133.2011.10686.x] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
14
|
Peuvrel L, Quéreux G, Brocard A, Saint-Jean M, Vallet C, Mère A, Labetoulle G, Le Fol C, Dréno B. Evaluation of Quality of Life after a Medical Corrective Make-Up Lesson in Patients with Various Dermatoses. Dermatology 2012; 224:374-80. [DOI: 10.1159/000339478] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2012] [Accepted: 05/14/2012] [Indexed: 11/19/2022] Open
|
15
|
Miyachi Y, Hayashi N, Furukawa F, Akamatsu H, Matsunaga K, Watanabe S, Kawashima M. Acne management in Japan: study of patient adherence. Dermatology 2011; 223:174-81. [PMID: 22025005 DOI: 10.1159/000332847] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2011] [Accepted: 09/03/2011] [Indexed: 11/19/2022] Open
Abstract
Obtaining good adherence to acne therapy is a challenge for all dermatologists. We studied 428 acne patients in Japan to determine the likelihood of good adherence and factors associated with medication-taking. This study utilized a simple validated questionnaire to assess risk of poor adherence; information about patient and treatment characteristics was also collected. There was an overall rate of poor adherence in 76% of subjects. Adherence to topical medication was poor in 52% of those treated with a topical agent only (n = 123). Among those taking combination therapies (n = 275), adherence to the topical portion of therapy was poor in 49% of subjects. The likelihood of poor adherence to oral medication was higher, both when administered alone (n = 30, 93% poor adherence) and when given as part of a combination regimen (n = 275, 86%). Factors with an impact on adherence included satisfaction with treatment (p = 0.023) and the experience of side effects (p = 0.027). Patients who felt they had a good understanding of acne and its treatment were more likely to have good adherence. These data suggest that there is significant room for improvement in acne adherence in Japan, as in other areas of the world, and that improved education may enhance adherence.
Collapse
Affiliation(s)
- Yoshiki Miyachi
- Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
| | | | | | | | | | | | | |
Collapse
|
16
|
JEON HC, CHO SY, LEE JH. Does long-pulsed neodymium:yttrium-aluminum-garnet work on acne lesions?: Management of acne in Asian patients with a combinational laser treatment. J Dermatol 2011; 38:802-5. [DOI: 10.1111/j.1346-8138.2010.01108.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
17
|
Feldman SR, Tan J, Poulin Y, Dirschka T, Kerrouche N, Manna V. The efficacy of adapalene-benzoyl peroxide combination increases with number of acne lesions. J Am Acad Dermatol 2011; 64:1085-91. [DOI: 10.1016/j.jaad.2010.03.036] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/28/2010] [Revised: 03/15/2010] [Accepted: 03/28/2010] [Indexed: 10/18/2022]
|
18
|
Tan J, Gollnick HPM, Loesche C, Ma YM, Gold LS. Synergistic efficacy of adapalene 0.1%-benzoyl peroxide 2.5% in the treatment of 3855 acne vulgaris patients. J DERMATOL TREAT 2010; 22:197-205. [DOI: 10.3109/09546631003681094] [Citation(s) in RCA: 34] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
19
|
Lott R, Taylor SL, O’Neill JL, Krowchuk DP, Feldman SR. Medication adherence among acne patients: a review. J Cosmet Dermatol 2010; 9:160-6. [DOI: 10.1111/j.1473-2165.2010.00490.x] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|